Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Veloxis Pharma Raises USD60 Million in Debt Financing 10
Private Equity 11
Veloxis Raises USD60 Million in Private Placement of Notes 11
Partnerships 12
Veloxis Pharma Enters Into Distribution Agreement With Chiesi Farmaceutici For LCP-Tacro 12
Licensing Agreements 13
Chiesi Farmaceutici Enters into Licensing Agreement with Veloxis Pharma 13
Paladin Labs Enters into Licensing Agreement with Veloxis Pharma 14
Taiba Pharma Enters into Licensing Agreement with Veloxis Pharma 15
Equity Offering 16
Veloxis Pharma Raises Funds through Private Placement of Shares upon Exercise of Warrants 16
Veloxis Pharma Raises Funds through Private Placement of Shares upon Exercise of Warrants 17
Veloxis Pharma Raises Funds through Private Placement of Shares upon Exercise of Warrants 18
Veloxis Pharma Raises USD0.6 Million in Private Placement of Shares 19
Veloxis Pharmaceuticals A/S – Key Competitors 20
Veloxis Pharmaceuticals A/S – Key Employees 21
Veloxis Pharmaceuticals A/S – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 13, 2018: Veloxis Pharmaceuticals announces financial results for the first six months of 2018 23
May 14, 2018: Veloxis Pharmaceuticals Announces Financial Results for the First Three Months of 2018 24
Feb 27, 2018: Veloxis Pharmaceuticals Releases Annual Report for 2017 25
Nov 14, 2017: Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2017 26
Aug 16, 2017: Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2017 27
May 16, 2017: Veloxis Pharmaceuticals Announces Financial Results for the First Three Months of 2017 28
Feb 28, 2017: Veloxis Pharmaceuticals Releases Annual Report for 2016 29
Corporate Communications 30
Oct 31, 2018: Ira Duarte promoted to chief financial officer of Veloxis Pharmaceuticals 30
Sep 24, 2018: Morten Marott Steps Down as Chief Financial Officer of Veloxis Pharmaceuticals 31
Apr 03, 2018: Veloxis Appoints Morten Marott as Chief Financial Officer 32
Sep 20, 2017: Alastair McEwan Steps Down as Chief Operating Officer of Veloxis Pharmaceuticals 33
Sep 13, 2017: Veloxis Pharmaceuticals Appoints Ulf Meier-Kriesche, MD, as Chief Scientific Officer 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veloxis Pharmaceuticals A/S, Deals By Therapy Area, 2012 to YTD 2018 8
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Veloxis Pharma Raises USD60 Million in Debt Financing 10
Veloxis Raises USD60 Million in Private Placement of Notes 11
Veloxis Pharma Enters Into Distribution Agreement With Chiesi Farmaceutici For LCP-Tacro 12
Chiesi Farmaceutici Enters into Licensing Agreement with Veloxis Pharma 13
Paladin Labs Enters into Licensing Agreement with Veloxis Pharma 14
Taiba Pharma Enters into Licensing Agreement with Veloxis Pharma 15
Veloxis Pharma Raises Funds through Private Placement of Shares upon Exercise of Warrants 16
Veloxis Pharma Raises Funds through Private Placement of Shares upon Exercise of Warrants 17
Veloxis Pharma Raises Funds through Private Placement of Shares upon Exercise of Warrants 18
Veloxis Pharma Raises USD0.6 Million in Private Placement of Shares 19
Veloxis Pharmaceuticals A/S, Key Competitors 20
Veloxis Pharmaceuticals A/S, Key Employees 21
Veloxis Pharmaceuticals A/S, Subsidiaries 22
List of Figures
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Veloxis Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8